EPOCH chemotherapy: toxicity and efficacy in relapsed and refractory non-Hodgkin's lymphoma.

Wilson, W H; Bryant, G; Bates, S; Fojo, A; Wittes, R E; Steinberg, S M; Kohler, D R; Jaffe, E S; Herdt, J; Cheson, B D

Wilson, W H; Bryant, G; Bates, S; Fojo, A; Wittes, R E; Steinberg, S M; Kohler, D R; Jaffe, E S; Herdt, J; Cheson, B D.

Affiliation

Wilson WH; Medicine Branch, National Cancer Institute, Bethesda, MD 20892.

J Clin Oncol ; 11(8): 1573-82, 1993 Aug.

Article in En | MEDLINE | ID: mdl-7687667

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Lymphoma, Non-Hodgkin/drug therapy; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Cyclophosphamide/administration & dosage; Doxorubicin/administration & dosage; Drug Administration Schedule; Drug Resistance; Etoposide/administration & dosage; Female; Granulocyte Colony-Stimulating Factor/therapeutic use; Humans; Infusions, Intravenous; Male; Middle Aged; Neutropenia/chemically induced; Neutropenia/drug therapy; Prednisone/administration & dosage; Recurrence; Survival Analysis; Treatment Outcome; Vincristine/administration & dosage

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Non-Hodgkin / Antineoplastic Combined Chemotherapy Protocols Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Clin Oncol Year: 1993 Document type: Article Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links